banner investors 1920x462

Company Profile

CURE Pharmaceutical is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety and the patient experience through its proprietary drug dosage forms and delivery systems. CURE has a full-service cGMP manufacturing facility and is a pioneering developer and manufacturer of a patented and proprietary delivery system (CUREfilm™), one of the most advanced oral thin film on the market today. CURE is developing an array of products in cutting-edge delivery platforms and partners with biotech and pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel and Germany, among other markets. The company’s mission is to improve people’s lives by redefining how medicines are delivered and experienced.

Download Our Investor Presentation

Stock Price: Today

Past Six Months

Key Contacts

Investor Relations

Liviakis Financial Communications, Inc.
655 Redwood Hwy., Suite 395
Mill Valley, CA 94942
(415) 389-04670
www.liviakis.com

Transfer Agent

VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
Phone: (212) 828-8436
Facsimile: (646) 536-3179
www.VStockTransfer.com

Auditors

RBSM, LLP
805 3rd Ave., #1430
New York, NY 10022
(917) 229-4610

Corporate Counsel

Carmel, Milazzo & DiChiara, LLP
55 West 39th Street, 18th Floor Penthouse
New York, New York 10018
(212) 658-0458